Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus souche a/darwin/9/2021 (h3n2)-like: reassortant virus san-010 derived from a/darwin/9/2021), haemagglutininum influenzae b (virus souche b/austria/1359417/2021-like: derived from b/michigan/01/2021 (victoria lineage)(wild type)) - suspension injectable en seringue préremplie - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019) 60 µg, haemagglutininum influenzae a (h3n2) (virus souche a/darwin/9/2021 (h3n2)-like: reassortant virus san-010 derived from a/darwin/9/2021) 60 µg, haemagglutininum influenzae b (virus souche b/austria/1359417/2021-like: derived from b/michigan/01/2021 (victoria lineage)(wild type)) 60 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage) (wild type)) 60 µg, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas anhydricus, octoxinolum-9, aqua ad iniectabile q.s. ad suspensionem pro 0.7 ml corresp. natrium 2.72 mg. - immunisation active contre l'influenza, dès 65 ans - vaccini

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/darwin/9/2021 (h3n2)-like: reassortant virus derived from a/darwin/9/2021, san-010), haemagglutininum influenzae b (virus-stamm b/austria/1359417/2021 -like: reassortant virus bvr-26 derived from b/austria/1359417/2021 (victoria lineage)) - sospensione iniettabile - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/darwin/9/2021 (h3n2)-like: reassortant virus derived from a/darwin/9/2021, san-010) 15 µg, haemagglutininum influenzae b (virus-stamm b/austria/1359417/2021 -like: reassortant virus bvr-26 derived from b/austria/1359417/2021 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 6 monaten - vaccini

Taliansko - taliančina - AIFA (Agenzia Italiana del Farmaco)

integratori tonico energetici

Taliansko - taliančina - AIFA (Agenzia Italiana del Farmaco)

integratori tonico energetici

Taliansko - taliančina - AIFA (Agenzia Italiana del Farmaco)

istituto biochimico pavese spa -

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

permamed ag - acido flufenamicum, hydroxyethylis salicylas, heparinum natricum - crema - acidum flufenamicum 35 mg, hydroxyethylis salicylas 100 mg, heparinum natricum 2000 u.i., macrogoli 2 stearas, glyceroli stearas et natrii laurilsulfas 5 mg, propylenglycolum 40 mg, isopropylis myristas, arachidis oleum hydrogenatum 25 mg, macrogoli 150 stearas, dimeticonum, rosmarini aetheroleum, pentadecalactonum, aqua purificata, ad gelatum pro 1 g. - kutanes antiphlogisticum - biotechnologika

Švajčiarsko - taliančina - Swissmedic (Swiss Agency for Therapeutic Products)

soho flordis international switzerland sa - ginseng extractum ethanolicum siccum - tonico elisir - estratto di ginseng ethanolicum lavaggio 42 - 77 mg corrisp. ginsenosidea 5.6 mg, der: 3-7:1, sono, colore.: e 150a, excipiens ad una soluzione per 15 ml, corrisp. ethanolum 12 % v/v. - tonico-stimolante - phytoarzneimittel